Federal Register of Legislation - Australian Government

Primary content

PB 65 of 2020 Determinations/Health as made
This determination amends the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019 to change the safety net recording fee used in the calculation of the price of certain pharmaceutical benefits for safety net purposes with effect from 1 July 2020.
Administered by: Health
Registered 29 Jun 2020
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 65 of 2020

 

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment (Seventh Community Pharmacy Agreement) Determination 2020

I, Natasha Ploenges, as delegate of the Minister for Health, make the following determination.

Dated 26 June 2020

Natasha Ploenges
Acting Assistant Secretary
Pharmacy Branch
Technology Assessment and Access Division

Department of Health

 

  

  


Contents

1............ Name............................................................................................................................. 1

2............ Commencement............................................................................................................. 1

3............ Authority....................................................................................................................... 1

4............ Schedules...................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019 2

 


1  Name

             (1)  This instrument is the National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Amendment (Seventh Community Pharmacy Agreement) Determination 2020.

             (2)  This instrument may also be cited as PB 65 of 2020.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 July 2020.

1 July 2020

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 84C(7) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1Amendments

  

National Health (Pharmaceutical Benefits) (Subsection 84C(7) Price) Determination 2019

1  Section 5 (definition of admixed ready‑prepared pharmaceutical benefit)

Repeal the definition.

2  Subsection 6(1)

Repeal the subsection, substitute:

             (1)  For the purposes of subsection 84C(7) of the Act, the price for a pharmaceutical benefit (of a particular quantity or number of units) is to be ascertained by adding:

                     (a)  the Commonwealth price for the supply of the benefit by an approved pharmacist, worked out in accordance with the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020); and

                     (b)  the amount of the additional patient charge; and

                     (c)  either:

                              (i)  if the pharmaceutical benefit is a ready‑prepared pharmaceutical benefit—$1.29; or

                             (ii)  if the pharmaceutical benefit is an extemporaneously‑prepared pharmaceutical benefit—$1.66.

Note:          This subsection complies with subsection 84C(8) of the Act because, to comply with subsection 98B(2) of the Act, the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020):

(a)    uses as a basis the approved ex‑manufacturer price, a proportional ex‑manufacturer price or the basic wholesale price; and

(b)    provides for the addition of other fees and amounts determined by the Tribunal that made the determination.